MWG Biotech AG - Continuation of lab automation line secured through AVISO GmbH

08-Feb-2005

MWG Biotech AG announces the transfer of its lab automation business to the automation specialist AVISO GmbH effective February 1. With this transaction the international continuation of the innovative robotics line is secured on a high quality level through AVISO GmbH. AVISO will also take over 15 of MWG Biotech's former lab automation employees. All servicing and warranty services will be continued by AVISO GmbH. In the Western part of the US Synquatech Inc, a spin-out of MWG employees led by Michael Winniman, will take over the lab automation services and sales as an AVISO partner. All other areas will be directly served by AVISO. Transaction details were not disclosed.

"With this transaction MWG Biotech AG closes a major chapter of its restructuring process. At the same time this solution ensures that MWG Biotech's PCR and liquid handling system customers will continue to receive competent high quality services. We are happy that the innovative THEONYX Liquid Handling platform will now be further developed in the market by AVISO GmbH ", says Dr. Wolfgang Pieken, Speaker of the Management Board of MWG Biotech AG.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Novartis and Gen-Probe Agree to Extend and Expand Blood Screening Collaboration - Companies will work together to protect the world's supply of donated blood from infectious diseases until 2025

Cell Therapeutics' subsidiary PanGenex introduces technology for high-throughput, cell-based screening of new cancer targets - Technology described at international scientific conference

LION Bioscience, Ltd. Signs Collaboration Agreement with European Molecular Biology Laboratory

DiagnoCure partner launches new prostate cancer test in Europe

On the trail of cancer stem cells - What goes on inside and between individual cells during the very earliest stages of tumor development?

On the trail of cancer stem cells - What goes on inside and between individual cells during the very earliest stages of tumor development?

BIOBASE übernimmt Proteome Inc. von Incyte Corp. - Internationale Firmenübernahme im Bereich Bioinformatik

Icon Genetics and Novoplant announce broad license agreement

Researchers identify non-culturable microbes from bloodstream infections

Scientists Discover New Molecular Markers for Testicular Cancer - Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells

Hospira Announces $2 Billion Agreement to Acquire Mayne Pharma

MOLOGEN: Executive Board orients towards new commercial tasks

DeveloGen and Scientists from IPK Gatersleben Publish Data on Key Trigger for Regenerating Insulin Producing Cells - Study Provides Additional Support in Fight to Treat Diabetes